• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number S46045
Device Problem Patient-Device Incompatibility (2682)
Event Date 11/18/2016
Event Type  Injury  
Manufacturer Narrative
A1: no patient specific details have been provided.Therefore, the patient initials reflect the study number with codes for the hospital and patient.H3 other code: as the device remains implanted, no further investigation can be performed.H6 evaluation codes investigation findings c19 refers to the product history review: a review of the manufacturing records indicated the lot met all pre-release specifications.The physician stated that there is no allegation against the gore-tex stretch vascular graft and that the graft did not contribute to the steal syndrome.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
Gore received an adverse event alert from a retrospective vascular graft study.On (b)(6) 2016, the patient underwent surgical treatment for a humero axillary dialysis access with a gore-tex® stretch vascular graft.The device was implanted and retained and there were no adverse events during the procedure.The patient was discharged home 1 week later.The first order to dialyze through the graft was on (b)(6) 2016 and was successful.On (b)(6) 2016, the patient presented with a vascular steal syndrome on the humero-axillary prosthetic line.Professor rinckenbach stated that there is no allegation against the gore-tex stretch vascular graft and that the graft did not contribute to the steal syndrome.There was a reintervention on (b)(6) 2016, namely banding of the arterio-venous anastomosis.The patient was discharged home on (b)(6) 2016 and an ultrasound performed on (b)(6) 2016 showed that everything was ok.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE-TEX® STRETCH VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
gunter marte
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key17675909
MDR Text Key322613946
Report Number2017233-2023-04248
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00733132611492
UDI-Public00733132611492
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K903931
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,User Facility
Reporter Occupation Physician
Type of Report Initial
Report Date 09/04/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2021
Device Catalogue NumberS46045
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/07/2023
Initial Date FDA Received09/04/2023
Was Device Evaluated by Manufacturer? No
Date Device Manufactured09/01/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient SexFemale
-
-